Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Positive Xanamem® human PET study published in the Journal of Alzheimer's Disease demonstrating robust CNS[1] target enzyme occupancy
2024-01-24 21:30
FDA CLEARANCE OF AMPLIA'S IND FOR PANCREATIC CANCER TRIAL IN US
2024-01-18 10:31
Style3D Research Shines the Show with additional Two Papers Accepted at SIGGRAPH ASIA 2023 on Cloth Simulation Innovations
2024-01-11 02:00
Seeing Machines unveils latest Guardian technology at CES 2024
2024-01-09 21:00
Canadian Solar's e-STORAGE to Deliver 220 MWh DC of Battery Storage Solutions to Epic Energy's Mannum Project in South Australia
2024-01-08 20:05
Recurrent Energy Completes Sale of 100 MW/200 MWh Battery Energy Storage Project in South Australia to Epic Energy
2024-01-08 20:00
GPN Vaccines Reports Positive Safety and Immunogenicity Data from its Phase 1 Trial of Gamma-PN
2024-01-04 04:30
APL-2301, a compound developed by Asieris for the treatment of Acinetobacter baumannii infection, was approved for Phase I clinical trials in Australia
2023-12-24 17:53
Following a digital Rebrand, Little Black Book Looks Back at a Decade of Exponential Growth and Record Turnover
2023-12-20 04:16
Neuren Phase 2 trial shows significant improvements in Phelan-McDermid syndrome
2023-12-18 19:00
Lunit Advances to Stage 2 of Australia's National Breast Cancer Screening Project
2023-12-11 22:30
IonOpticks and Newomics broaden chromatography accessibility for Agilent mass specs, with Shimadzu pending
2023-12-07 07:04
Registrational Phase III CLARIFY trial in prostate cancer commences
2023-11-30 22:16
First patient with metastatic prostate cancer to receive 2 doses of Cu-67 SAR-bisPSMA achieves undetectable PSA level
2023-11-30 21:59
Leading AI decisioning platform Rich Data Co successfully raises $17.5 million in Series B round to accelerate North America expansion
2023-11-30 07:13
Clarity's theranostic prostate cancer trial progresses at the highest dose level cohort
2023-11-29 21:58
Telstra Broadcast Services and BT Announce Strategic Alliance to Enhance Global Network Connectivity
2023-11-21 13:30
First Subject Enrolled in Phase 1 Study of MRX-5
2023-11-20 18:34
HaemaLogiX Announces Appointment of Damian Clarke-Bruce as Managing Director and CEO
2023-11-14 08:27
6clicks GRC Platform Adds Automated Cybersecurity Incident Tracking and Reporting to Meet New SEC Disclosure Requirements
2023-11-14 06:29
1
2
3
4
5
109